Publication | Closed Access

Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in α-emitter therapy for disseminated ovarian cancer

Drug TargetingMedicineα-Emitter TherapyPharmacologyGynecologyDisseminated Ovarian CancerTumor TargetingAnti-cancer AgentCancer TreatmentOncologyTumor BiologyPeptidic LigandsOvarian Cancer